196 related articles for article (PubMed ID: 22206454)
21. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
[TBL] [Abstract][Full Text] [Related]
22. Response to commentary on a trial comparing krill oil versus fish oil.
Ramprasath VR; Eyal I; Zchut S; Jones PJ
Lipids Health Dis; 2014 Jan; 13():17. PubMed ID: 24447440
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
Su X; Tanalgo P; Bustos M; Dass CR
Curr Drug Targets; 2018; 19(5):479-486. PubMed ID: 25563592
[TBL] [Abstract][Full Text] [Related]
24. Determination and structural elucidation of triacylglycerols in krill oil by chromatographic techniques.
Araujo P; Zhu H; Breivik JF; Hjelle JI; Zeng Y
Lipids; 2014 Feb; 49(2):163-72. PubMed ID: 24190513
[TBL] [Abstract][Full Text] [Related]
25. Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.
Yarbrough WM; Mukherjee R; Stroud RE; Meyer EC; Escobar GP; Sample JA; Hendrick JW; Mingoia JT; Spinale FG
J Cardiovasc Pharmacol; 2010 Apr; 55(4):408-16. PubMed ID: 20147844
[TBL] [Abstract][Full Text] [Related]
26. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
27. Microencapsulated krill and tuna oil blend raises plasma long-chain n-3 polyunsaturated fatty acid levels compared to tuna oil with similar increases in ileal contractility in rats.
Patten GS; Sanguansri L; Augustin MA; Abeywardena MY; Bird AR; Patch CS; Belobrajdic DP
Int J Food Sci Nutr; 2017 Mar; 68(2):201-209. PubMed ID: 27643849
[TBL] [Abstract][Full Text] [Related]
28. A krill oil supplemented diet suppresses hepatic steatosis in high-fat fed rats.
Ferramosca A; Conte A; Burri L; Berge K; De Nuccio F; Giudetti AM; Zara V
PLoS One; 2012; 7(6):e38797. PubMed ID: 22685607
[TBL] [Abstract][Full Text] [Related]
29. Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies.
Liu Y; Robinson AM; Su XQ; Nurgali K
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672464
[TBL] [Abstract][Full Text] [Related]
30. Dietary polyunsaturated fatty acids and adaptation to chronic hypoxia alter acyl composition of serum and heart lipids.
Balková P; Jezková J; Hlavácková M; Neckár J; Stanková B; Kolár F; Novák F; Nováková O
Br J Nutr; 2009 Nov; 102(9):1297-307. PubMed ID: 19480730
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction.
Hongo M; Sentianin EM; Tanaka N; Mao L; McKirnan MD; Clark RG; Won W; Chien KR; Ross J
J Card Fail; 1998 Sep; 4(3):213-24. PubMed ID: 9754592
[TBL] [Abstract][Full Text] [Related]
32. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial.
Köhler A; Sarkkinen E; Tapola N; Niskanen T; Bruheim I
Lipids Health Dis; 2015 Mar; 14():19. PubMed ID: 25884846
[TBL] [Abstract][Full Text] [Related]
34. A brief review of krill oil history, research, and the commercial market.
Kwantes JM; Grundmann O
J Diet Suppl; 2015 Mar; 12(1):23-35. PubMed ID: 24689485
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction.
Cittadini A; Grossman JD; Napoli R; Katz SE; Strömer H; Smith RJ; Clark R; Morgan JP; Douglas PS
J Am Coll Cardiol; 1997 Apr; 29(5):1109-16. PubMed ID: 9120168
[TBL] [Abstract][Full Text] [Related]
36. Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications.
Colletti A; Cravotto G; Citi V; Martelli A; Testai L; Cicero AFG
Mar Drugs; 2021 May; 19(6):. PubMed ID: 34073184
[No Abstract] [Full Text] [Related]
37. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
38. Dietary fish oil preserves cardiac function in the hypertrophied rat heart.
McLennan PL; Abeywardena MY; Dallimore JA; Raederstorff D
Br J Nutr; 2012 Aug; 108(4):645-54. PubMed ID: 22067847
[TBL] [Abstract][Full Text] [Related]
39. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction.
Soeki T; Kishimoto I; Schwenke DO; Tokudome T; Horio T; Yoshida M; Hosoda H; Kangawa K
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H426-32. PubMed ID: 18024547
[TBL] [Abstract][Full Text] [Related]
40. The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
Lygate CA; Hulbert K; Monfared M; Cole MA; Clarke K; Neubauer S
Cardiovasc Res; 2003 Jun; 58(3):632-7. PubMed ID: 12798436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
